FDA Approved: LORAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lorazepam from Hikma Pharmaceuticals USA Inc., authorizing the marketing of a Lorazepam product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Epilepsy

Drugs mentioned

• Lorazepam (Lorazepam)

Snippet

SUPPL AP for LORAZEPAM (LORAZEPAM)